These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2946282)

  • 1. Ocular penetration, toxicity, and radiosensitization effects of two hypoxic cell radiosensitizers on retinoblastoma.
    Rootman J; Gallie B; Kumi C; Bussanich N; Rogers B; Palcic B
    Arch Ophthalmol; 1986 Nov; 104(11):1693-7. PubMed ID: 2946282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ocular absorption and toxicity of a radiosensitizer and its effect on hypoxic cells.
    Rootman J; Josephy PD; Adomat H; Palcic B
    Arch Ophthalmol; 1982 Mar; 100(3):468-71. PubMed ID: 7199901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiosensitizing effects of misonidazole and SR 2508 on a human melanoma transplanted in nude mice: influence on repair of potentially lethal damage.
    Guichard M; Malaise EP
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):465-8. PubMed ID: 6213589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KIH-802, an acetohydroxamic acid derivative of 2-nitroimidazole, as a new potent hypoxic cell radiosensitizer: radiosensitizing activity, acute toxicity, and pharmacokinetics.
    Sasai K; Shibamoto Y; Takahashi M; Zhou L; Hori H; Nagasawa H; Shibata T; Inayama S; Abe M
    Cancer Chemother Pharmacol; 1990; 26(2):112-6. PubMed ID: 2140730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical trials of radiosensitizers: what should we expect?
    Brown JM
    Int J Radiat Oncol Biol Phys; 1984 Mar; 10(3):425-9. PubMed ID: 6231272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiosensitization by a new nucleoside analogue: 1-[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl-2-nitroimidazole (RP-170).
    Murayama C; Suzuki A; Suzuki T; Miyata Y; Sakaguchi M; Tanabe Y; Tanaka N; Mori T
    Int J Radiat Oncol Biol Phys; 1989 Sep; 17(3):575-81. PubMed ID: 2528527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiosensitization of hypoxic cells in vivo by SR 2508 at low radiation doses: a preliminary report.
    Brown JM; Yu NY
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1207-12. PubMed ID: 6236184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Present status of hypoxic cell sensitizers and PLDR inhibitors].
    Ono K; Sasai K; Shibamoto Y; Tsutsui K; Fushiki M; Nishidai T; Takahashi M; Abe M
    Gan No Rinsho; 1987 Oct; 33(13):1673-8. PubMed ID: 2961900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The multi-dose clinical tolerance and pharmacokinetics of the combined radiosensitizers, Ro 03-8799 (pimonidazole) and SR 2508 (etanidazole).
    Newman HF; Ward R; Workman P; Bleehen NM
    Int J Radiat Oncol Biol Phys; 1988 Nov; 15(5):1073-83. PubMed ID: 2972667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of photodynamic therapy alone and in combination with misonidazole or X-rays for management of a retinoblastoma-like tumour.
    Winther J; Overgaard J; Ehlers N
    Photochem Photobiol; 1988 Mar; 47(3):419-23. PubMed ID: 2967981
    [No Abstract]   [Full Text] [Related]  

  • 11. Hypoxic cell radiosensitizers in the treatment of high grade gliomas: a new direction using combined Ro 03-8799 (pimonidazole) and SR 2508 (etanidazole).
    Newman HF; Bleehen NM; Ward R; Workman P
    Int J Radiat Oncol Biol Phys; 1988 Sep; 15(3):677-84. PubMed ID: 2843488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiosensitization by the combination of etanidazole (SR-2508) and pimonidazole (Ro 03-8799) in human tumor xenografts.
    Taghian A; Lespinasse F; Guichard ME
    Int J Radiat Oncol Biol Phys; 1991 Nov; 21(6):1535-40. PubMed ID: 1834621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies in radiosensitizing effects of misonidazole and SR-2508 on C3H/He mouse mammary tumors.
    Ono K; Takahashi M; Nishidai T; Dodo Y; Shibamoto Y; Hiraoka M; Yukawa Y; Abe M
    Radiat Med; 1984; 2(1):71-5. PubMed ID: 6242712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response of an ocular melanoma to subconjunctival injection of 5-thio-D-glucose or cis-platin.
    Skov KA; Kumi C; Rootman J; Bussanich N; Fellenz MO
    Br J Cancer; 1987 May; 55(5):499-502. PubMed ID: 3606943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase I study of the combined hypoxic cell radiosensitizers, Ro 03-8799 and SR 2508: a preliminary report of single-dose toxicity, pharmacokinetics and tumour concentrations.
    Newman HF; Bleehen NM; Workman P
    Br J Radiol; 1986 Apr; 59(700):423-5. PubMed ID: 2938660
    [No Abstract]   [Full Text] [Related]  

  • 16. A comparison of the cytological effects of three hypoxic cell radiosensitizers.
    Spunberg JJ; Geard CR; Rutledge-Freeman MH
    Int J Radiat Oncol Biol Phys; 1982 Jul; 8(7):1207-15. PubMed ID: 6214532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiosensitization by the combination of SR-2508 and paclitaxel in hypoxic human tumor cells in vitro.
    Jin C; Bai L; Guo G
    J Radiat Res; 2007 May; 48(3):179-85. PubMed ID: 17420623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concentrations achieved in human tumors after administration of misonidazole, SR-2508 and Ro 03-8799.
    Dische S; Saunders MI; Dunphy EP; Bennett MH; Des Rochers C; Stratford MR; Minchinton AI; Orchard RA
    Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1109-11. PubMed ID: 2943708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Radiosensitization of hypoxic tumor cells with special reference to head and neck cancers].
    Kogelnik HD
    Wien Klin Wochenschr; 1983 Aug; 95(15):515-8. PubMed ID: 6636784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined cytokinesis-block micronucleus and chromosomal aberration assay for the evaluation of radiosensitizers at low radiation doses.
    Oya N; Shibamoto Y; Shibata T; Sasai K; Sugiyama T; Abe M
    Int J Radiat Oncol Biol Phys; 1994 Dec; 30(5):1153-9. PubMed ID: 7961025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.